Print friendly version
Progressive multifocal leukoencephalopathy
Other Names for this Disease
- Leukoencephalopathy, progressive multifocal
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
Currently, the best available therapy is reversal of the immune-deficient state. This can sometimes be accomplished by alteration of chemotherapy or immunosuppression. In the case of HIV-associated PML, immediately beginning anti-retroviral therapy will benefit most individuals.
Last updated: 3/3/2011
- NINDS Progressive Multifocal Leukoencephalopathy Information Page. National Institute of Neurological Disorders and Stroke (NINDS). 2010; http://www.ninds.nih.gov/disorders/pml/pml.htm. Accessed 3/3/2011.
Clinical Trials & Research for this Disease
- ClinicalTrials.gov lists trials that are studying or have studied Progressive multifocal leukoencephalopathy. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.